We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical's Debottleneck Projects to Boost Capacity
Read MoreHide Full Article
Eastman Chemical Company (EMN - Free Report) has reaffirmed its commitment to alkyl amines’ production at its global integrated assets situated in North America, Europe and Asia. The chemical maker has several debottlenecking projects underway to continuously increase capacity for meeting the rising global demand.
Its most recent debottleneck was completed in the third quarter of 2019 and another is anticipated to be completed in 2020.
Alkyl amines, which are part of the company’s Chemical Intermediates segment, are used in a wide range of end markets such as home and personal care, animal nutrition, and water treatment.
In the third quarter, Chemical Intermediates sales declined 18% year over year to $579 million, hurt by lower selling prices and reduced sales volumes, especially for functional amine products and intermediates.
Shares of Eastman Chemical have lost 2.2% in the past year compared with the industry’s 22.8% decline.
The company recorded a profit of $266 million or $1.93 per share in the third quarter, down roughly 35% from the year-ago profit of $412 million or $2.89 per share. Its adjusted earnings per share of $1.94 missed the Zacks Consensus Estimate of $1.99.
The company’s revenues dipped around 9% year over year to $2,325 million in the quarter. Moreover, the top line missed the Zacks Consensus Estimate of $2,365.9 million.
Eastman Chemical anticipates sales volume and capacity utilization to decline for the fourth quarter due to the worsening of the global business environment, resulting from trade uncertainties and other macro factors. Considering the factors, it anticipates adjusted earnings per share of $7.00-$7.20 for 2019.
Amid the difficult business environment, the company remains focused on managing costs and growing new business revenues from innovation, especially in the Advanced Materials segment.
Impala Platinum has an expected earnings growth rate of 248.3% for the current fiscal year. The company’s shares have surged 243.7% in the past year.
Franco-Nevada has a projected earnings growth rate of 46.2% for 2019. The company’s shares have rallied 44.3% in a year.
Agnico Eagle has an estimated earnings growth rate of 168.6% for the current year. Its shares have moved up 67.8% in the past year.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Eastman Chemical's Debottleneck Projects to Boost Capacity
Eastman Chemical Company (EMN - Free Report) has reaffirmed its commitment to alkyl amines’ production at its global integrated assets situated in North America, Europe and Asia. The chemical maker has several debottlenecking projects underway to continuously increase capacity for meeting the rising global demand.
Its most recent debottleneck was completed in the third quarter of 2019 and another is anticipated to be completed in 2020.
Alkyl amines, which are part of the company’s Chemical Intermediates segment, are used in a wide range of end markets such as home and personal care, animal nutrition, and water treatment.
In the third quarter, Chemical Intermediates sales declined 18% year over year to $579 million, hurt by lower selling prices and reduced sales volumes, especially for functional amine products and intermediates.
Shares of Eastman Chemical have lost 2.2% in the past year compared with the industry’s 22.8% decline.
The company recorded a profit of $266 million or $1.93 per share in the third quarter, down roughly 35% from the year-ago profit of $412 million or $2.89 per share. Its adjusted earnings per share of $1.94 missed the Zacks Consensus Estimate of $1.99.
The company’s revenues dipped around 9% year over year to $2,325 million in the quarter. Moreover, the top line missed the Zacks Consensus Estimate of $2,365.9 million.
Eastman Chemical anticipates sales volume and capacity utilization to decline for the fourth quarter due to the worsening of the global business environment, resulting from trade uncertainties and other macro factors. Considering the factors, it anticipates adjusted earnings per share of $7.00-$7.20 for 2019.
Amid the difficult business environment, the company remains focused on managing costs and growing new business revenues from innovation, especially in the Advanced Materials segment.
Eastman Chemical Company Price and Consensus
Eastman Chemical Company price-consensus-chart | Eastman Chemical Company Quote
Zacks Rank & Stocks to Consider
Eastman Chemical currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the basic materials space are Impala Platinum Holdings Ltd. (IMPUY - Free Report) , Franco-Nevada Corporation (FNV - Free Report) and Agnico Eagle Mines Limited (AEM - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Impala Platinum has an expected earnings growth rate of 248.3% for the current fiscal year. The company’s shares have surged 243.7% in the past year.
Franco-Nevada has a projected earnings growth rate of 46.2% for 2019. The company’s shares have rallied 44.3% in a year.
Agnico Eagle has an estimated earnings growth rate of 168.6% for the current year. Its shares have moved up 67.8% in the past year.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>